Skip to content
The Reel — swipe today’s market
Nukoud

iShares Biotechnology ETF

IBB USUSExchange-Traded Fund
$186.49
Health

About this fund

iShares Biotechnology ETF (IBB) is a Health ETF managed by BlackRock Fund Advisors, listed on Nasdaq - All Markets in USD. It charges a 0.44% net expense ratio and holds $9.95K in assets as of Aug 13, 2026. The fund tracks NYSE Biotechnology TR USD and was launched on Feb 5, 2001.

Benchmark
NYSE Biotechnology TR USD
Advisor
BlackRock Fund Advisors
Exchange
Nasdaq - All Markets
Distribution
Quarterly
AUM
$9.95K
Expense Ratio
0.44%
Yield (12-mo)
0.00%
Morningstar Rating
Benchmark
NYSE Biotechnology TR USD
52-Week Range
Avg Daily Vol
1.57M
Inception
Feb 5, 2001

Risk metrics

vs benchmark NYSE Biotechnology TR USD

3-year risk statistics are not currently available for this fund.

Risk statistics are 3-year, month-end-based.

Trailing returns

As of Aug 13, 2026
1D
+0.49%
1W
+4.65%
1M
+4.51%
3M
+16.52%
6M
+17.73%
YTD
+19.03%
1Y
+50.17%
3Y ann.
+16.33%
5Y ann.
+3.75%
10Y ann.
+7.75%

Calendar-year returns

Morningstar daily closes

Trading & liquidity

as of Aug 12, 2026

Avg Vol (1W)
1.77M
Avg Vol (1M)
1.46M
Avg Vol (3M)
1.57M
Avg Vol (1Y)
1.78M
Avg Spread
0.035%

Average daily share volume over each trailing window. Spread is the average bid-ask spread as a percentage of price — lower means cheaper to trade.

Top 10 holdings

Source: Morningstar

Fees & expenses

Net expense
0.44%
Gross expense
0.44%
Management fee
0.44%

Distributions

12-month yield

0.00%

Recent payments per share (USD)

Jun 15, 2026
0.0238 USD
Mar 17, 2026
0.1218 USD
Dec 16, 2025
0.1831 USD
Sep 16, 2025
0.0828 USD

Classification

Category
Health
Investment Type
Exchange-Traded Fund
Strategic Beta
No
Strategy
Not Applicable
Issuer
BlackRock Fund Advisors
Branding
iShares

Frequently asked questions

What is IBB's expense ratio?
iShares Biotechnology ETF charges a net expense ratio of 0.440%.
How large is iShares Biotechnology ETF?
IBB holds $9.95K in assets under management.
What index does IBB track?
iShares Biotechnology ETF tracks NYSE Biotechnology TR USD as its primary benchmark.
When did IBB launch?
iShares Biotechnology ETF launched on February 5, 2001.
What currency does IBB trade in?
IBB trades in USD on Nasdaq - All Markets.

Fund information

Ticker
IBB
Performance ID
0P00002DAH
Inception
Feb 5, 2001
Domicile
USA
Base currency
USD
Listing currency
USD
AUM
$9.95K
Avg daily volume (3M)
1.57M

Charting by TradingView.

Powered by Morningstar